Last, we reported a newly diagnosed AQP4-positive NMOSD (Case 6), in a patient—with a previous history of two optic neuritis- presenting with LETM and brainstem involvement after BNT162b2 second dose. The gene discussed is AQP4; the disease is optic neuritis.